BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Childhood. 1997;76:518-521. [PMID: 9245850 DOI: 10.1136/adc.76.6.518] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, Lesure F, Delattre P, Lakhdari M, Meyer D, Girma J, Loriat C. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. The Journal of Pediatrics 2003;142:310-7. [DOI: 10.1067/mpd.2003.79] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
2 Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM. Síndrome hemolítico urémico atípico. Medicina Clínica 2015;145:438-45. [DOI: 10.1016/j.medcli.2014.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Greenwood GT. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab. Int Med Case Rep J 2015;8:235-9. [PMID: 26508891 DOI: 10.2147/IMCRJ.S90640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Raina R, Vijayvargiya N, Khooblall A, Melachuri M, Deshpande S, Sharma D, Mathur K, Arora M, Sethi SK, Sandhu S. Pediatric Atypical Hemolytic Uremic Syndrome Advances. Cells 2021;10:3580. [PMID: 34944087 DOI: 10.3390/cells10123580] [Reference Citation Analysis]
5 Gami AS, Hayman SR, Grande JP, Garovic VD. Incidence and prognosis of acute heart failure in the thrombotic microangiopathies. Am J Med. 2005;118:544-547. [PMID: 15866258 DOI: 10.1016/j.amjmed.2005.02.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
6 Asif A, Vachharajani T, Salman L, Nayer A. A Simplified Approach to the Diagnosis of Atypical HUS: Clinical Considerations and Practical Implications. TOUNJ 2014;7:91-4. [DOI: 10.2174/1874303x01407010091] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Prestidge C, Wong W. Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children. Journal of Paediatrics and Child Health 2009;45:731-5. [DOI: 10.1111/j.1440-1754.2009.01603.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
8 Hofer J, Rosales A, Fischer C, Giner T. Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr. 2014;2:97. [PMID: 25250305 DOI: 10.3389/fped.2014.00097] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
9 Michael M, Elliott EJ, Craig JC, Ridley G, Hodson EM. Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials. American Journal of Kidney Diseases 2009;53:259-72. [DOI: 10.1053/j.ajkd.2008.07.038] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
10 Ince E, Kuloglu Z, Akinci Z. Hemorrhagic shock and encephalopathy syndrome: Neurologic features: . Pediatric Emergency Care 2000;16:260-4. [DOI: 10.1097/00006565-200008000-00012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, Vigil J. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer 1999;85:2023-32. [DOI: 10.1002/(sici)1097-0142(19990501)85:9<2023::aid-cncr21>3.0.co;2-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
12 Van Hove JL, Van Damme-Lombaerts R, Grünewald S, Peters H, Van Damme B, Fryns JP, Arnout J, Wevers R, Baumgartner ER, Fowler B. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet 2002;111:195-201. [PMID: 12210350 DOI: 10.1002/ajmg.10499] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
13 Noris M, Remuzzi G. Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 2014;10:174-80. [DOI: 10.1038/nrneph.2013.280] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
14 Niaudet P. Syndrome hémolytique et urémique chez l’enfant. EMC - Pédiatrie 2004;1:379-85. [DOI: 10.1016/j.emcped.2004.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Herbert AP, Uhrín D, Lyon M, Pangburn MK, Barlow PN. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J Biol Chem 2006;281:16512-20. [PMID: 16533809 DOI: 10.1074/jbc.M513611200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
16 Almalki AH, Sadagah LF, Qureshi M, Maghrabi H, Algain A, Alsaeed A. Atypical hemolytic-uremic syndrome due to complement factor I mutation. World J Nephrol 2017; 6(6): 243-250 [PMID: 29226095 DOI: 10.5527/wjn.v6.i6.243] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009;:CD003595. [PMID: 19160220 DOI: 10.1002/14651858.CD003595.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
18 Gulleroglu K, Fidan K, Hançer VS, Bayrakci U, Baskin E, Soylemezoglu O. Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 2013;28:827-30. [PMID: 23389237 DOI: 10.1007/s00467-013-2416-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
19 Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol. 2003;18:1095-1101. [PMID: 13680331 DOI: 10.1007/s00467-003-1289-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
20 Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007;22:2097-103. [PMID: 17874135 DOI: 10.1007/s00467-007-0604-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
21 Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 2002;24:327-9. [PMID: 11972107 DOI: 10.1097/00043426-200205000-00023] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
22 Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011;2011:908407. [PMID: 21876803 DOI: 10.4061/2011/908407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
23 Amirlak I, Amirlak B. Haemolytic uraemic syndrome: an overview. Nephrology (Carlton) 2006;11:213-8. [PMID: 16756634 DOI: 10.1111/j.1440-1797.2006.00556.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
24 Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet. 2003;362:1542-1547. [PMID: 14615110 DOI: 10.1016/s0140-6736(03)14742-3] [Cited by in Crossref: 239] [Cited by in F6Publishing: 71] [Article Influence: 13.3] [Reference Citation Analysis]
25 Kakajiwala A, Bhatti T, Kaplan BS, Ruebner RL, Copelovitch L. Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab? Clin Kidney J 2016;9:90-6. [PMID: 26798467 DOI: 10.1093/ckj/sfv119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
26 Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, Vigil J. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer. 1999;85:2023-2032. [PMID: 10223245 DOI: 10.1002/(sici)1097-0142(19990501)85:9%3c2023::aid-cncr21%3e3.0.co;2-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 1] [Article Influence: 2.9] [Reference Citation Analysis]
27 Bui TTT, Billing H, Alrajab A, Wühl E, Schenk J. Long-term investigation of kidney ultrasound in cases of hemolytic uremic syndrome in children. J Med Ultrasonics 2014;41:187-96. [DOI: 10.1007/s10396-013-0504-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
28 Cooper M, McGraw ME, Unsworth DJ, Mathieson P. Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome. Nephrol Dial Transplant 2004;19:230-3. [PMID: 14671063 DOI: 10.1093/ndt/gfg470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
29 Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet. 2003;12:3385-3395. [PMID: 14583443 DOI: 10.1093/hmg/ddg363] [Cited by in Crossref: 230] [Cited by in F6Publishing: 209] [Article Influence: 12.1] [Reference Citation Analysis]
30 Niaudet P. Syndrome hémolytique et urémique chez l’enfant. Néphrologie & Thérapeutique 2008;4:34-40. [DOI: 10.1016/j.nephro.2007.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
31 van de Kar N, Monnens L. 15 The haemolytic-uraemic syndrome in childhood. Baillière's Clinical Haematology 1998;11:497-507. [DOI: 10.1016/s0950-3536(98)80063-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Yenerel MN. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management. Turk J Haematol 2014;31:216-25. [PMID: 25319590 DOI: 10.4274/tjh.2013.0374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008;3:249-77. [PMID: 18215115 DOI: 10.1146/annurev.pathmechdis.3.121806.154311] [Cited by in Crossref: 139] [Cited by in F6Publishing: 106] [Article Influence: 9.9] [Reference Citation Analysis]
34 Kichloo A, Chugh SS, Gupta S, Pandav J, Chander P. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy. J Investig Med High Impact Case Rep 2019;7:2324709619842905. [PMID: 31010328 DOI: 10.1177/2324709619842905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol 2019;34:1337-48. [PMID: 30109445 DOI: 10.1007/s00467-018-4039-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
36 Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 2017;30:347-62. [PMID: 27848226 DOI: 10.1007/s40620-016-0357-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
37 Salem G, Flynn JM, Cataland SR. Profound neurological injury in a patient with atypical hemolytic uremic syndrome. Ann Hematol 2013;92:557-8. [DOI: 10.1007/s00277-012-1615-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
38 Ruebner RL, Kaplan BS, Copelovitch L. A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same? Eur J Pediatr 2012;171:1519-25. [PMID: 22673930 DOI: 10.1007/s00431-012-1763-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
39 Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 2015;35:421-47. [PMID: 26456110 DOI: 10.1016/j.nefro.2015.07.005] [Cited by in Crossref: 88] [Cited by in F6Publishing: 63] [Article Influence: 12.6] [Reference Citation Analysis]
40 Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012;119:4182-91. [PMID: 22246034 DOI: 10.1182/blood-2011-10-383281] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 9.7] [Reference Citation Analysis]
41 Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60:831-846. [PMID: 11532079 DOI: 10.1046/j.1523-1755.2001.060003831.x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 228] [Article Influence: 14.5] [Reference Citation Analysis]